These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16775668)

  • 1. Effects of withdrawal of Xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with coronary artery disease.
    Hu CL; Li YB; Tang YH; Chen JB; Liu J; Tang QZ; Zhang QH; Huang CX
    Cardiovasc Drugs Ther; 2006 Jun; 20(3):185-91. PubMed ID: 16775668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of xuezhikang at different doses on patients suffering from acute coronary syndrome after percutaneous coronary intervention].
    Jiang FY; Sun LP; Yang J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Dec; 31(12):1607-10. PubMed ID: 22384544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with stable angina.
    Li JJ; Hu SS; Fang CH; Hui RT; Miao LF; Yang YJ; Gao RL
    Clin Chim Acta; 2005 Feb; 352(1-2):217-24. PubMed ID: 15653117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of plasma inflammatory markers after withdrawal of statin therapy in patients with hyperlipidemia.
    Li JJ; Li YS; Chu JM; Zhang CY; Wang Y; Huang Y; Chen J; Yuan JQ; Huang YL
    Clin Chim Acta; 2006 Apr; 366(1-2):269-73. PubMed ID: 16343471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of Xuezhikang on serum levels of high sensitive-C reactive protein, matrix metalloproteinase-9 and lipoprotein in patients with acute coronary syndrome].
    Huang J; Wang MH; Peng XP; Wei C; Lu J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Mar; 26(3):221-3. PubMed ID: 16613266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Xuezhikang in patients with dyslipidemia: a multicenter, randomized, placebo-controlled study.
    Moriarty PM; Roth EM; Karns A; Ye P; Zhao SP; Liao Y; Capuzzi DM; Bays HE; Zhang F; Liu S; Reichman AJ; Brusco OA; Lu G; Lerman S; Duan Z; Guo S; Liu PL; Zhao J; Zhang Y; Li S
    J Clin Lipidol; 2014; 8(6):568-575. PubMed ID: 25499939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of withdrawal of statin on C-reactive protein.
    Lee KT; Lai WT; Chu CS; Tsai LY; Yen HW; Voon WC; Sheu SH
    Cardiology; 2004; 102(3):166-70. PubMed ID: 15334028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease.
    Zhao SP; Liu L; Cheng YC; Shishehbor MH; Liu MH; Peng DQ; Li YL
    Circulation; 2004 Aug; 110(8):915-20. PubMed ID: 15313947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term effects of xuezhikang, an extract of cholestin, on serum proprotein convertase subtilisin/kexin type 9 levels.
    Jia YJ; Zhang Y; Liu J; Guo YL; Xu RX; Li JJ
    Chin J Integr Med; 2016 Feb; 22(2):96-100. PubMed ID: 24993334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of Guizhi Fuling Decoction on YKL-40 and hs-CRP of patients with non-ST segment elevation acute coronary syndrome].
    Pei Q; Sang WF; Zhao XD
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Feb; 33(2):186-90. PubMed ID: 23646472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of xuezhikang on blood lipids, serum oxidized low density lipoprotein, C-reactive protein and fibrinogen in patients with unstable angina pectoris].
    Yao QH; Cui CC; Wang JK
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Oct; 23(10):750-2. PubMed ID: 14626188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction.
    Lu Z; Kou W; Du B; Wu Y; Zhao S; Brusco OA; Morgan JM; Capuzzi DM; ; Li S
    Am J Cardiol; 2008 Jun; 101(12):1689-93. PubMed ID: 18549841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
    Bays HE; Davidson M; Jones MR; Abby SL
    Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of triangle drugs as ginseng, Trichosanthes kirilowii maxim and rhubarb on the level of blood lipids and related pro-inflammatory cytokines during the process of treating atherosclerosis].
    Wang JY; Wu SX; Jiang LD
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 May; 31(5):667-71. PubMed ID: 21812271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xuezhikang, an extract of cholestin, decreases plasma inflammatory markers and endothelin-1, improve exercise-induced ischemia and subjective feelings in patients with cardiac syndrome X.
    Li JJ; Wang Y; Nie SP; Li Q; Li YS; Huang Y; Hui RT
    Int J Cardiol; 2007 Oct; 122(1):82-4. PubMed ID: 17196275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term effects of atorvastatin on C-reactive protein.
    Riesen WF; Engler H; Risch M; Korte W; Noseda G
    Eur Heart J; 2002 May; 23(10):794-9. PubMed ID: 12009719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of xuezhlkang capsule in intervening different Chinese medical syndrome patterns of non-alcoholic fatty liver disease complicated with carotid atherosclerosis].
    Ou MY; Xu SH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Feb; 31(2):159-63. PubMed ID: 21425565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
    Feldman T; Davidson M; Shah A; Maccubbin D; Meehan A; Zakson M; Tribble D; Veltri E; Mitchel Y
    Clin Ther; 2006 Jun; 28(6):849-59. PubMed ID: 16860168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of jingtian tongmai recipe on atherosclerotic plaque in rabbits].
    Zhao CX; Kasimu R; Wang XM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Feb; 29(2):136-9. PubMed ID: 19382474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.